Mink Therapeutics Inc (NASDAQ:INKT) I think this recent IPO play has found support around the $3.7-$4.5 range and looks poised to post a bounce from here. I could see a 30-50% possible bounce up to $6.40 - $8 a share if it can get break resistance at $4.60. Keep in mind, the IPO was at 12 in October and hit 22 in November. I think current prices are going to look awfully cheap down the road. Plus, it's also a COVID Name. On Nov 12th, the company announced 77% Survival Rate in Intubated Patients with COVID-19 Respiratory Failure Treated with AgenT-797. Definitely one to watch for a big bounce.